Common metabolic drug helps memory in mice

Share this article:
A drug that has until now been prescribed to treat patients with a certain metabolic disorder has been found to improve the memory of laboratory animals with Alzheimer's disease, according to a recent report.

Sodium phenylbutyrate is commonly used to treat patients who experience an alteration in the urea cycle. Researchers discovered that the drug also helped certain proteins, which are responsible for neuron connections, fuse together, resulting in improved learning capacity of lab mice. Researchers at the Center for Applied Medical Research (CIMA) at the University of Navarra are investigating which element of the drug is responsible for the beneficial effects.

Because sodium phenylbutyrate is already available for use, researchers suggest it could potentially be used to treat Alzheimer's and other dementia patients much sooner than other experimental drugs. The report was published in the journal Neuropsychopharmacology.
Share this article:

More in News

NY nursing home agrees to $2.2 million settlement in case of false documentation

NY nursing home agrees to $2.2 million settlement ...

Nursing home operator Ralex Services Inc. has agreed to a $2.2 million settlement in a whistleblower case involving forged documents at a facility in New Rochelle, New York.

Common soaps could endanger healthcare workers, study finds

Healthcare facilities should consider replacing antibacterial soaps containing the chemical triclosan, University of California-San Francisco researchers assert in a recent Journal of Occupational and Environmental Medicine article. The conclusion echoes recently updated hand hygiene guidelines.

Mandatory staff hours, better high-acuity care could improve quality of life in ...

A nursing home's staffing patterns and admissions trends are among the most important factors driving residents' quality of life over time, according to recently published research findings.